237 related articles for article (PubMed ID: 32812860)
21. Construction and immunogenicity of recombinant porcine circovirus-like particles displaying somatostatin.
Li W; Wang X; Bai J; Ma T; Li Z; Li Y; Jiang P
Vet Microbiol; 2013 Apr; 163(1-2):23-32. PubMed ID: 23294858
[TBL] [Abstract][Full Text] [Related]
22. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
[TBL] [Abstract][Full Text] [Related]
23. Short communication: a modified Vaccinia virus Ankara-based Porcine circovirus 2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model.
de Oliveira Daian E Silva DS; Barbosa-Stancioli EF; Coelho-Dos-Reis JGA; Da Fonseca FG
Braz J Microbiol; 2020 Sep; 51(3):1439-1445. PubMed ID: 32144692
[TBL] [Abstract][Full Text] [Related]
24. Assessment of neutralizing and non-neutralizing antibody responses against Porcine circovirus 2 in vaccinated and non-vaccinated farmed pigs.
Solis Worsfold C; Dardari R; Law S; Eschbaumer M; Nourozieh N; Marshall F; Czub M
J Gen Virol; 2015 Sep; 96(9):2743-2748. PubMed ID: 26033118
[TBL] [Abstract][Full Text] [Related]
25. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
[TBL] [Abstract][Full Text] [Related]
26. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
[TBL] [Abstract][Full Text] [Related]
27. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
Zepeda-Cervantes J; Cruz-Reséndiz A; Sampieri A; Carreón-Nápoles R; Sánchez-Betancourt JI; Vaca L
Vaccine; 2019 Mar; 37(14):1928-1937. PubMed ID: 30824359
[TBL] [Abstract][Full Text] [Related]
29. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
Zanotti C; Martinelli N; Lelli D; Amadori M
Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
[TBL] [Abstract][Full Text] [Related]
30. PCV cap proteins fused with calreticulin expressed into polymers in Escherichia coli with high immunogenicity in mice.
Liu C; Liu Y; Feng H; Zhao B; Chen Y; Huang H; Wang P; Deng R; Zhang G
BMC Vet Res; 2020 Aug; 16(1):313. PubMed ID: 32854700
[TBL] [Abstract][Full Text] [Related]
31. Comparison of Immune Responses to the PCV2 Replicase-Capsid and Capsid Virus-Like Particle Vaccines in Mice.
Jung BK; Kim HR; Lee YH; Jang H; Chang KS
J Microbiol Biotechnol; 2019 Mar; 29(3):482-488. PubMed ID: 30609882
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
[TBL] [Abstract][Full Text] [Related]
33. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
Alberti KA; Estienne MJ; Meng XJ
J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
[TBL] [Abstract][Full Text] [Related]
34. Immune responses of piglets immunized by a recombinant plasmid containing porcine circovirus type 2 and porcine interleukin-18 genes.
Chen GL; Fu PF; Wang LQ; Li XS; Chen HY
Viral Immunol; 2014 Dec; 27(10):521-8. PubMed ID: 25268976
[TBL] [Abstract][Full Text] [Related]
35. Immunogenicity of adenovirus vaccines expressing the PCV2 capsid protein in pigs.
Li D; Du Q; Wu B; Li J; Chang L; Zhao X; Huang Y; Tong D
Vaccine; 2017 Aug; 35(36):4722-4729. PubMed ID: 28755834
[TBL] [Abstract][Full Text] [Related]
36. Immunogenicity and immunoprotection of porcine circovirus type 2 (PCV2) Cap protein displayed by Lactococcus lactis.
Li PC; Qiao XW; Zheng QS; Hou JB
Vaccine; 2016 Jan; 34(5):696-702. PubMed ID: 26372858
[TBL] [Abstract][Full Text] [Related]
37. Characterization and epitope mapping of monoclonal antibodies recognizing N-terminus of Rep of porcine circovirus type 2.
Meng T; Jia Q; Liu S; Karuppannan AK; Chang CC; Kwang J
J Virol Methods; 2010 May; 165(2):222-9. PubMed ID: 20152863
[TBL] [Abstract][Full Text] [Related]
38. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
[TBL] [Abstract][Full Text] [Related]
39. Impact of maternally derived immunity on piglets' immune response and protection against porcine circovirus type 2 (PCV2) after vaccination against PCV2 at different age.
Martelli P; Saleri R; Ferrarini G; De Angelis E; Cavalli V; Benetti M; Ferrari L; Canelli E; Bonilauri P; Arioli E; Caleffi A; Nathues H; Borghetti P
BMC Vet Res; 2016 May; 12():77. PubMed ID: 27170186
[TBL] [Abstract][Full Text] [Related]
40. Immunogenicity Evaluation of Modified Adenovirus Vaccines Expressing Porcine Circovirus Type 2 Capsid Protein in Pigs.
Li D; Xu D; Wang Z; Du Q; Chang L; Zhao X; Huang Y; Tong D
Viral Immunol; 2017 Mar; 30(2):111-119. PubMed ID: 27996636
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
